scispace - formally typeset
Search or ask a question
Institution

University of Amsterdam

EducationAmsterdam, Noord-Holland, Netherlands
About: University of Amsterdam is a education organization based out in Amsterdam, Noord-Holland, Netherlands. It is known for research contribution in the topics: Population & Context (language use). The organization has 59309 authors who have published 140894 publications receiving 5984137 citations. The organization is also known as: UvA & Universiteit van Amsterdam.


Papers
More filters
Journal ArticleDOI
TL;DR: This article showed that moderate levels of task conflict may promote team innovation, but it simultaneously reduces short-term goal attainment in teams, and the effects of conflict are mediated by collaborative problem solving.

636 citations

Journal ArticleDOI
01 Feb 1999-Cancer
TL;DR: The objective of the current study was to examine the late effects on neuropsychologic functioning of CMF adjuvant chemotherapy given to patients with breast carcinoma.
Abstract: BACKGROUND A number of patients who have undergone adjuvant (CMF) chemotherapy for operative primary breast carcinoma have reported impaired cognitive function, sometimes even years after completion of therapy. The possible role of cytostatic treatment as a causative factor has scarcely been investigated. The objective of the current study was to examine the late effects on neuropsychologic functioning of CMF adjuvant chemotherapy given to patients with breast carcinoma. METHODS Thirty-nine breast carcinoma patients who had been treated with adjuvant CMF (6 courses) followed (n = 20) by 3 years of tamoxifen 20 mg daily or not (n = 19) were examined with neuropsychologic tests and interviews. The control group consisted of 34 age-matched axillary lymph node negative breast carcinoma patients who received the same surgical and radiation therapy but no systemic adjuvant treatment. The CMF patients were examined a median of 1.9 years after the sixth CMF course, and the controls a median of 2.4 years after surgery of the primary tumor. RESULTS Patients treated with CMF reported significantly more problems with concentration (31% vs. 6%, P = 0.007) and with memory (21% vs. 3%, P = 0.022) than the control patients. No relation was found between reported complaints and results on the neuropsychologic tests. Impairment in cognitive function was found in 28% of the patients treated with chemotherapy compared with 12% of the patients in the control group (odds ratio 6.4 [95% confidence interval 1.5–27.6] P = 0.013). Hormonal therapy had no influence on patients' self-reports of symptoms or cognitive function. Cognitive impairment following chemotherapy was noticed in a broad domain of functioning, including attention, mental flexibility, speed of information processing, visual memory, and motor function. CONCLUSIONS Breast carcinoma patients treated with adjuvant CMF chemotherapy have a significantly higher risk of late cognitive impairment than breast carcinoma patients not treated with chemotherapy (OR 6.4). This cognitive impairment is unaffected by anxiety, depression, fatigue, and time since treatment, and not related to the self-reported complaints of cognitive dysfunction. Cancer 1999;85:640–50. © 1999 American Cancer Society.

635 citations

Journal ArticleDOI
TL;DR: Manganese oxides of different crystallinity, oxidation state and specific surface area have been used in the selective catalytic reduction (SCR) of nitric oxide with ammonia, indicating a relation between the SCR process and active surface oxygen.
Abstract: Manganese oxides of different crystallinity, oxidation state and specific surface area have been used in the selective catalytic reduction (SCR) of nitric oxide with ammonia between 385 and 575 K. MnO2 appears to exhibit the highest activity per unit surface area, followed by Mn5O8, Mn2O3, Mn3O4 and MnO, in that order. This SCR activity correlates with the onset of reduction in temperature-programmed reduction (TPR) experiments, indicating a relation between the SCR process and active surface oxygen. Mn2O3 is preferred in SCR since its selectivity towards nitrogen formation during this process is the highest. In all cases the selectivity decreases with increasing temperature. The oxidation state of the manganese, the crystallinity and the specific surface area are decisive for the performance of the oxides. The specific surface area correlates well with the nitric oxide reduction activity. The nitrous oxide originates from a reaction between nitric oxide and ammonia below 475 K and from oxidation of ammonia at higher temperatures, proven by using 15NH3. Participation of the bulk oxygen of the manganese oxides can be excluded, since TPR reveals that the bulk oxidation state remains unchanged during SCR, except for MnO, which is transformed into Mn3O4 under the applied conditions. In the oxidation of ammonia the degree of oxidation of the nitrogen containing products (N2, N2O, NO) increases with increasing temperature and with increasing oxidation state of the manganese. A reaction model is proposed to account for the observed phenomena.

634 citations

Journal ArticleDOI
01 Mar 2013-Gut
TL;DR: In this paper, a 49-expert multidisciplinary international consortium met to discuss pancreatic screening and vote on statements on screening, surveillance and management of high-risk individuals with an inherited predisposition to pancreatic cancer.
Abstract: Background Screening individuals at increased risk for pancreatic cancer (PC) detects early, potentially curable, pancreatic neoplasia. Objective To develop consortium statements on screening, surveillance and management of high-risk individuals with an inherited predisposition to PC. Methods A 49-expert multidisciplinary international consortium met to discuss pancreatic screening and vote on statements. Consensus was considered reached if ≥75% agreed or disagreed. Results There was excellent agreement that, to be successful, a screening programme should detect and treat T1N0M0 margin-negative PC and high-grade dysplastic precursor lesions (pancreatic intraepithelial neoplasia and intraductal papillary mucinous neoplasm). It was agreed that the following were candidates for screening: first-degree relatives (FDRs) of patients with PC from a familial PC kindred with at least two affected FDRs; patients with Peutz–Jeghers syndrome; and p16, BRCA2 and hereditary non-polyposis colorectal cancer (HNPCC) mutation carriers with ≥1 affected FDR. Consensus was not reached for the age to initiate screening or stop surveillance. It was agreed that initial screening should include endoscopic ultrasonography (EUS) and/or MRI/magnetic resonance cholangiopancreatography not CT or endoscopic retrograde cholangiopancreatography. There was no consensus on the need for EUS fine-needle aspiration to evaluate cysts. There was disagreement on optimal screening modalities and intervals for follow-up imaging. When surgery is recommended it should be performed at a high-volume centre. There was great disagreement as to which screening abnormalities were of sufficient concern to for surgery to be recommended. Conclusions Screening is recommended for high-risk individuals, but more evidence is needed, particularly for how to manage patients with detected lesions. Screening and subsequent management should take place at high-volume centres with multidisciplinary teams, preferably within research protocols.

634 citations

Journal ArticleDOI
TL;DR: It is suggested that the inhibition of Nlrp3 inflammasome activity can diminish the acute inflammation and damage associated with tissue injury.
Abstract: Dying cells are capable of activating the innate immune system and inducing a sterile inflammatory response. Here, we show that necrotic cells are sensed by the Nlrp3 inflammasome resulting in the subsequent release of the proinflammatory cytokine IL-1β. Necrotic cells produced by pressure disruption, hypoxic injury, or complement-mediated damage were capable of activating the Nlrp3 inflammasome. Nlrp3 inflammasome activation was triggered in part through ATP produced by mitochondria released from damaged cells. Neutrophilic influx into the peritoneum in response to necrotic cells in vivo was also markedly diminished in the absence of Nlrp3. Nlrp3-deficiency moreover protected animals against mortality, renal dysfunction, and neutrophil influx in an in vivo renal ischemic acute tubular necrosis model. These findings suggest that the inhibition of Nlrp3 inflammasome activity can diminish the acute inflammation and damage associated with tissue injury.

634 citations


Authors

Showing all 59759 results

NameH-indexPapersCitations
Richard A. Flavell2311328205119
Scott M. Grundy187841231821
Stuart H. Orkin186715112182
Kenneth C. Anderson1781138126072
David A. Weitz1781038114182
Dorret I. Boomsma1761507136353
Brenda W.J.H. Penninx1701139119082
Michael Kramer1671713127224
Nicholas J. White1611352104539
Lex M. Bouter158767103034
Wolfgang Wagner1562342123391
Jerome I. Rotter1561071116296
David Cella1561258106402
David Eisenberg156697112460
Naveed Sattar1551326116368
Network Information
Related Institutions (5)
University College London
210.6K papers, 9.8M citations

94% related

University of Edinburgh
151.6K papers, 6.6M citations

94% related

University of Pennsylvania
257.6K papers, 14.1M citations

94% related

Columbia University
224K papers, 12.8M citations

94% related

University of Pittsburgh
201K papers, 9.6M citations

94% related

Performance
Metrics
No. of papers from the Institution in previous years
YearPapers
2023198
2022699
20219,646
20208,532
20197,821
20186,407